Jefferies raises ResMed target price to $240 from $220
RMD•Jefferies raised its target price for RESMED INC. to $240 from $220.
Related News
Alnylam Pharmaceuticals: RBC cuts target price to $280 from $345
ALNY•
Bank of New York Mellon target price raised to $166.50 from $161
BK•
Hershey: JP Morgan cuts target price to $166 from $183
HSY•
Dexcom target price raised to $97 from $90 by Canaccord Genuity
DXCM•
AGCO Corporation: JP Morgan raises target price to $145 from $140
AGCO•